Searched for
COVAXIN EUL
Bharat Biotech must address WHO's Covaxin suspension to avoid EUL cancellation, says MEAThe Ministry of External Affairs said many issues about vaccines and international travel by Indians have arisen and these must be addresse...- Guidelines on Covaxin for under 18 don't mention EUL by WHO: Health MinistryThe guidelines issued by the Ministry on December 27, 2021, under the heading “New beneficiaries aged 15-18 years” state that "For such ben...
- Covaxin gets WHO approval for emergency use listingWHO's TAG is an independent advisory group that provides recommendations to the WHO on whether a Covid 19 vaccine can be listed for emergen...
- View: WHO's EUL for Covaxin will play a pivotal role in bridging global vaccine inequalitySome argue that it is not in the interest of existing vaccine manufacturers to have another competitor. However, this is improbable. We are...
- We trust Indian industry, Bharat Biotech has been submitting data regularly, very quickly: WHO official on Covaxin EULBharat Biotech's Covaxin and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India.
- WHO seeks 'additional clarifications' from Bharat Biotech for Covaxin to conduct final 'risk-benefit assessment'"The TAG met today (26 October 2021) and decided that additional clarifications from the manufacturer are needed to conduct a final EUL ris...
- Technical Advisory Group seeks additional clarification on Covaxin for Emergency Use ListingWhile the WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Jans...
- WHO's advisory group set to meet on October 26 to decide on Covaxin EUL approvalWhile the WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Jans...
- WHO to decide on Bharat Biotech's Covaxin clearance in OctoberSoumya Swaminathan, WHO's chief scientist, told ET that the "process is ongoing".
- Decision on Bharat Biotech's Covaxin EUL in October, says WHOThe latest 'Status of COVID-19 vaccines within WHO EUL/PQ evaluation process' guidance document dated September 29 on the WHO website said ...
- Process on track to get WHO nod for Covaxin, says Bharat BiotechAn emergency approval from the WHO will allow Bharat Biotech to export Covaxin to more countries and enable easy international travel for p...
- Bharat Biotech awaits feedback from WHO for Covaxin EULThe WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is yet "to be confirmed," acc...
- Mandaviya meets WHO Chief Scientist Soumya Swaminathan, discusses Covaxin approvalAll documents required for Emergency Use Listing have been submitted by Bharat Biotech for COVID-19 vaccine Covaxin to the WHO as of July 9...
- WHO has commenced review process for emergency use listing of Covaxin: GovtResponding to a question on whether it has come to the notice of the government that COVID-19 vaccine Covaxin used in India is not recognis...
- WHO assessing Covaxin data for emergency use listing; decision date 'to be confirmed'Suchitra Ella, joint managing director of Bharat Biotech, had recently said the EUL process is a step closer to the final decision on Covax...
- All documents for Covaxin emergency use listing submitted to WHO, expect approval at earliest: Bharat BiotechAccording to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public hea...
- Inching towards EUL by WHO for Covaxin: Bharat Biotech"We are working closely with the World Health Organisation for inclusion of Covaxin in its Emergency Use Listing. Approval from WHO is not ...
- Bharat Biotech's pre-submission meeting for Covaxin EUL with WHO on June 23The information was provided in the WHO website in the Status of COVID-19 Vaccines within WHO EUL-PQ evaluation process document.
- Covaxin phase-3 trial data to be out soon, says top executiveMore than five months after the Indian government approved Covaxin, the Hyderabad-based company has yet to publish its phase-3 trial data.
- More information required from Bharat Biotech for emergency use listing of Covaxin, says WHOWHO website said Bharat Biotech submitted EOI (Expression of Interest) on April 19 and that “More information required”.
Load More
